Propanc Biopharma, Inc. (PPCB): EPS (Basic)
-$17.62
Year ended 2026-06-30
| Period ended | EPS (Basic) | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | -$17.62 | n/m | 2026-09-25, From 2025-07-01 |
| 2025-06-30 | -$371.22 | n/c | 2026-09-25, From 2024-07-01 |
| 2024-06-30 | -$1420.53 | n/m | 2025-09-29, From 2023-07-01 |
| 2023-06-30 | -$1.80 | n/m | 2024-09-30, From 2022-07-01 |
| 2022-06-30 | -$49.23 | n/m | 2023-09-28, From 2021-07-01 |
| 2021-06-30 | -$0.80 | n/a | 2022-09-28, From 2020-07-01 |
EPS (Basic) at similar companies
| Company | Year ended | EPS (Basic) | Change YoY |
|---|---|---|---|
| Propanc Biopharma, Inc. (PPCB) | 2026-06-30 | -$17.62 | n/m |
| NRX Pharmaceuticals, Inc. (NRXP) | 2025-12-31 | -$1.34 | n/m |
| Imunon, Inc. (IMNN) | 2025-12-31 | -$6.83 | n/m |
| Turn Therapeutics Inc. (TTRX) | 2025-12-31 | -$0.12 | n/m |
| Edesa Biotech, Inc. (EDSA) | 2025-09-30 | -$1.27 | n/m |
| CalciMedica, Inc. (CALC) | 2025-12-31 | -$1.97 | n/m |
| PRF Technologies Ltd. (PRFX) | 2025-12-31 | -$7.47 | n/m |
| Chemomab Therapeutics Ltd. (CMMB) | 2025-12-31 | $0.018 | -53.8% |
| CytoDyn Inc. (CYDY) | 2026-05-31 | -$0.03 | n/a |
Compare PPCB, NRXP, IMNN, TTRX side by side · Screen every company in Pharmaceutical Preparations ↗